Maladie de Marek: vaccins polyvalents = Marek disease: polyvalent vaccinesBOUQUET, J. F.Point vétérinaire (Maisons-Alfort). 1986, Vol 18, Num 100, pp 477-481, issn 0335-4997Article

Myocarditis after triple immunisationAMSEL, S. G; HANUKOGLU, A; FRIED, D et al.Archives of disease in childhood. 1986, Vol 61, Num 4, pp 403-405, issn 0003-9888Article

Réflexions portant sur l'efficacité des nouveaux vaccins combinés. Discussion = Are the new combined vaccines efficacious ?BEGUE, P; BLANCHER, M. G; MOZZICONACCI, M. P et al.Bulletin de l'Académie nationale de médecine. 1998, Vol 182, Num 3, pp 567-579, issn 0001-4079Conference Paper

Evaluation of the reactogenicity and immunogenic potency of inactivated three-component influenza vaccine with the increased concentration of hemagglutinin in an immunization doseMARINICH, I. G; SHADRIN, A. S; SHAPOSHNIKOVA, V. I et al.Žurnal mikrobiologii, èpidemiologii i immunobiologii. 1991, Num 7, pp 58-61, issn 0372-9311Article

A vaccine against malaria: how far away is a magic shot?Africa health. 1987, Vol 10, Num 1, pp 14-15, issn 0141-9536Article

Vaccination antigrippale = Influenza vaccinationAYMARD, M.Virologie (Montrouge). 2002, Vol 6, pp S149-S160, issn 1267-8694, NSArticle

Développement des vaccins conjugués = Developemnt of conjugated vaccinesSOUBEYRAND, Benoit.MTP. Médecine thérapeutique pédiatrie. 2000, Vol 3, pp 25-27, issn 1286-5494, HS2Article

Live attenuated vaccine vectorsMEKALANOS, J. J.International journal of technology assessment in health care. 1994, Vol 10, Num 1, pp 131-142, issn 0266-4623Conference Paper

Vaccin polyvalent anti-Pseudomonas. Effets et mécanisme immunologique de la protectionSANG EUN LEE; YOUNG KYOON KIM.Sehur huidai hagsur ji. (Seoul journal of medicine). 1984, Vol 25, Num 3, pp 420-429, issn 0253-2972Article

Emergence of Invasive Pneumococcal Disease Caused by Nonvaccine Serotypes in the Era of 7-Valent Conjugate VaccineMUNOZ-ALMAGRO, Carmen; JORDAN, Iolanda; GENE, Amadeo et al.Clinical infectious diseases. 2008, Vol 46, Num 2, pp 174-185, issn 1058-4838, 12 p.Article

Safety and immunogenicity of a new influenza vaccine grown in mammalian cell cultureHALPERIN, S. A; NESTRUCK, A. C; EASTWOOD, B. J et al.Vaccine. 1998, Vol 16, Num 13, pp 1331-1335, issn 0264-410XArticle

Impact of a Pentavalent Combination Vaccine on Immunization Timeliness in a State Medicaid PopulationHAPPE, Laura E; LUNACSEK, Orsolya E; KRUZIKAS, Denise T et al.The Pediatric infectious disease journal. 2009, Vol 28, Num 2, pp 98-101, issn 0891-3668, 4 p.Article

Combined vaccines for Europe, pharmaceutical, regulatory and policy-makingaspectsANDRE, F; CHOLAT, J; FURMINGER, I et al.Biologicals (Print). 1994, Vol 22, Num 4, issn 1045-1056, 147 p.Conference Proceedings

Polyvalent recombinant antigens: a new vaccine strategyKINGSMAN, S. M; KINGSMAN, A. J.Vaccine. 1988, Vol 6, Num 4, pp 304-306, issn 0264-410XArticle

Immunocytochemical focus assay for potency determination of measles―mumps―rubella trivalent vaccineFUKUDA, A; HISHIYAMA, M; UMINO, Y et al.Journal of virological methods. 1987, Vol 15, Num 4, pp 279-284, issn 0166-0934Article

The impact of DTaP-IPV-HB vaccine on use of health services for young infantsTHOMPSON, Lindsay A; IRIGOYEN, Matilde; MATIZ, L. Adriana et al.The Pediatric infectious disease journal. 2006, Vol 25, Num 9, pp 826-831, issn 0891-3668, 6 p.Article

Développement du vaccin pneumocoque conjugué undécavalent = Devellopment of 11 serotype conjugated vaccinePLOTKIN, Stanley A.MTP. Médecine thérapeutique pédiatrie. 2000, Vol 3, pp 17-18, issn 1286-5494, HS2Article

Polyvalent vaccines in fish : The interactive effects of multiple antigensBUSCH, R. A.Developments in biological standardization. 1997, Num 90, pp 245-256, issn 0301-5149Conference Paper

Construction of Neisseria meningitidis strains carrying multiple chromosomal copies of the porA gene for use in the production of a multivalent outer membrane vesicle vaccineVAN DER LEY, P; VAN DER BIEZEN, J; POOLMAN, J. T et al.Vaccine. 1995, Vol 13, Num 4, pp 401-407, issn 0264-410XArticle

Immunogenicity of a polyvalent melanoma antigen vaccine in humansBYSTRYN, J.-C; ORATZ, R; HARRIS, M. N et al.Cancer. 1988, Vol 61, Num 6, pp 1065-1070, issn 0008-543XArticle

Qu'attendre de Prevenar® en pratique quotidienne ? = Prevenar in practiceCOHEN, R; REINERT, P; GAUDELUS, J et al.Médecine & enfance. 2001, Vol 21, Num 8, pp 413-416, issn 0291-0233, 1Article

The need for combination vaccinesKATZ, S. L.Archives of pediatrics & adolescent medicine. 1996, Vol 150, Num 3, pp 330-331, issn 1072-4710Article

Efficacy of a trivalent Haemophilus paragallinarum vaccine compared to bivalent vaccinesJACOBS, A. A. C; CUENEN, W; STORM, P. K et al.Veterinary microbiology (Amsterdam). 1992, Vol 32, Num 1, pp 43-49, issn 0378-1135Article

Use of highly purified subvirion trivalent influenza vaccine (Grippovac) in groups of high risk of complicationsCHUMAKOV, M. P; BEREGOVSKY, N. A; LINEV, M. B et al.Žurnal mikrobiologii, èpidemiologii i immunobiologii. 1992, Num 3, pp 55-57, issn 0372-9311Article

Cinétique de certains paramètres de l'immunité cellulaire chez des patients atteints de conjonctivite herpétique traités par un vaccin polyvalent herpétiqueBARINSKIJ, I. F; BLOKHA, V. V; BUKOVSKAYA, S. N et al.Voprosy virusologii. 1988, Vol 33, Num 2, pp 212-217, issn 0507-4088Article